Research Article
Assessment of the Isoniazid Preventive Therapy Uptake and Associated Characteristics: A Cross-Sectional Study
Table 4
Risk factors for nonuptake of IPT.
| Factors | OR (95% CI) | value | aOR (95% CI) | value |
| Child contacts | | | | | >3 Years | 7.0 (1.65–29) | 0.008 | 29 (2.17–400) | 0.011 | HIV positive | 5.0 (1.0–25) | 0.050 | 10 (0.61–174) | 0.105 | Not child of the index case | 3.4 (0.89–13) | 0.072 | 59 (2.74–127) | 0.009 | Index cases | | | | | HIV-positive | 4.0 (0.97–16.77) | 0.054 | 8.1 (2.53–537) | 0.038 | Household factors | | | | | Sex of the head of the household | 4.6 (1.18–17.9) | 0.028 | - | | Income < 50.000 Rwandan Franc | 0.1 (0.22–1.57) | 0.123 | 0.1 (0.01–1.01) | 0.050 | Heath facility factors | | | | | Provider not friendly | 10 (1.26–83) | 0.029 | 19 (2.514–140) | 0.017 |
|
|
IPT = isoniazid preventive therapy; HIV = human immunodeficiency virus; CI = confidence interval; OR = odds ratio; aOR = adjusted OR.
|